Could microbial therapy boost cancer immunotherapy?-Reference-Cited by-同舟云学术

Could microbial therapy boost cancer immunotherapy?

Published:2015-11-27 Issue:6264 Volume:350 Page:1031-1032
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Snyder Alexandra¹,Pamer Eric²,Wolchok Jedd³

Affiliation:

1. Department of Medicine, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY, USA.

2. Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Lucille Castori Center for Microbes, Inflammation, and Cancer, New York, NY, USA.

3. Swim across America–Ludwig Collaborative Research Laboratory, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, Immunology Program, Ludwig Center for Cancer Immunotherapy, New York, NY, USA.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference14 articles.

1. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

2. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy

3. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

4. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

5. Up-Regulation of PD-L1, IDO, and T regs in the Melanoma Tumor Microenvironment Is Driven by CD8 + T Cells

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor microbiota affects the efficacy of tea polyphenols therapy in breast tumor;Food Bioscience;2024-10

2. The gut microbiome and dietary metabolites in the treatment of renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2024-08

3. Exploring Gut Microbiome in Predicting the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer;Cancers;2022-11-02

4. Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy;Cancers;2022-10-28

5. Correlation between human gut microbiome and diseases;Infectious Medicine;2022-09